| |
| |
|
| Insider
Information: |
Crowley John F |
| Relationship: |
Director |
| City: |
Cranbury |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
590,194 |
|
|
Indirect Shares
|
97,759 |
|
|
| Direct
Value |
$6,353,484 |
|
|
|
Indirect Value
|
$688,536 |
|
|
| Total
Shares |
687,953 |
|
|
| Total
Value |
$7,042,020 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amicus Therapeutics Inc |
FOLD |
|
2024-03-01 |
573,478 |
2024-03-01 |
64,895 |
Premium* |
|
|
Intellia Therapeutics, Inc. |
NTLA |
Director |
2023-06-14 |
11,716 |
2021-06-23 |
0 |
Premium* |
|
|
Entrada Therapeutics, Inc. |
TRDA |
Director |
2022-01-12 |
5,000 |
2022-01-12 |
32,864 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
298 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 10 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2023-01-03 |
4 |
D |
$11.93 |
$263,844 |
D/D |
(22,116) |
747,742 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2022-01-02 |
4 |
D |
$11.55 |
$265,280 |
D/D |
(22,968) |
770,079 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2021-02-16 |
4 |
AS |
$12.26 |
$269,700 |
D/D |
(22,000) |
851,888 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2019-05-01 |
4 |
AS |
$13.51 |
$270,154 |
D/D |
(20,000) |
750,399 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2019-03-01 |
4 |
AS |
$12.97 |
$271,979 |
D/D |
(20,000) |
668,081 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2019-04-01 |
4 |
AS |
$13.63 |
$272,626 |
D/D |
(20,000) |
668,081 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2024-02-01 |
4 |
D |
$12.67 |
$273,621 |
D/D |
(21,596) |
729,242 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2017-10-18 |
4 |
OE |
$14.76 |
$280,544 |
D/D |
19,013 |
347,014 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2017-10-18 |
4 |
AS |
$14.76 |
$280,544 |
D/D |
(19,013) |
328,001 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2021-11-15 |
4 |
AS |
$11.75 |
$292,951 |
D/D |
(24,935) |
824,526 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2021-06-07 |
4 |
AS |
$10.01 |
$295,192 |
D/D |
(29,500) |
877,230 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2020-08-17 |
4 |
AS |
$14.89 |
$297,814 |
D/D |
(20,000) |
860,713 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
Director |
– • – |
2021-10-11 |
4 |
AS |
$119.55 |
$298,875 |
D/D |
(2,500) |
2,094 |
0 |
% |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2020-07-15 |
4 |
AS |
$15.54 |
$310,848 |
D/D |
(20,000) |
880,368 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2019-12-31 |
4 |
D |
$9.74 |
$322,228 |
D/D |
(33,083) |
702,611 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2017-10-13 |
4 |
AS |
$14.75 |
$326,867 |
D/D |
(22,160) |
328,001 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2017-10-13 |
4 |
OE |
$14.75 |
$326,867 |
D/D |
22,160 |
350,161 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2021-11-03 |
4 |
AS |
$12.00 |
$332,868 |
D/D |
(27,739) |
824,526 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2021-12-31 |
4 |
D |
$11.55 |
$363,582 |
D/D |
(31,479) |
793,047 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2021-08-05 |
4 |
AS |
$10.03 |
$371,047 |
D/D |
(37,000) |
847,345 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2020-12-31 |
4 |
D |
$23.09 |
$376,067 |
D/D |
(16,287) |
807,226 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2024-03-01 |
4 |
S |
$13.35 |
$389,543 |
D/D |
(29,181) |
573,478 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2024-02-01 |
4 |
S |
$12.62 |
$398,918 |
D/D |
(31,614) |
750,838 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2024-01-16 |
4 |
S |
$12.78 |
$404,106 |
D/D |
(31,614) |
837,779 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2020-10-01 |
4 |
AS |
$14.02 |
$419,105 |
D/D |
(29,900) |
840,913 |
0 |
- |
|
298 Records found
|
|
Page 10 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
